Project Grant R24AI194905
Award Date 8/20/25
Completion Date 7/31/30
Dollars Obligated $658K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06510, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a 5-year, $1,546,730 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to support the continuation and expansion of the Johns Hopkins HIV Implementation Science Hub (Hopkins Hub). The key objectives of this award are to: 1) enhance the technical rigor of implementation science research and build capacity among investigators focused on ending...
- This $859,083 Project Grant, awarded on August 21, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), supports the Southeastern HIV Implementation Science Hub led by Vanderbilt University Medical Center (VUMC). The Hub aims to enhance the sustained implementation of evidence-based HIV diagnosis, treatment, and prevention services among academic, community, and clinical partners in the southeastern U.S. The project will...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $1,505,785 Project Grant to Northwestern University to support the HIV Implementation Science Coordination Initiative (ISCI). The grant, awarded on Sep 3, 2025, with a completion date of Aug 31, 2030, aims to: 1) Integrate implementation and effectiveness data across NIAID's Ending the HIV Epidemic (EHE)-funded projects to create...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $721,721 to the University of California, Los Angeles (UCLA) to establish the UCLA RAPID, RIGOROUS, RELEVANT IMPLEMENTATION SCIENCE HUB. This five-year grant, running from August 1, 2025 to July 31, 2030, will leverage implementation science to enhance the translation of HIV research into routine clinical practice and improve population health outcomes. Key objectives include providing technical...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $812,427 to the University of California, San Diego (UCSD) to develop an interactive online data dashboard. The dashboard will integrate de-identified and aggregated HIV sequence data with publicly available Ending the HIV Epidemic (EHE) prevention and treatment data to identify regions with heightened HIV...
- This Project Grant award of $769,471 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports the "HIV Enhanced Access Testing in Emergency Department Program Using a Systems Analysis and Improvement Approach (HEATED-SAIA) Cluster Randomized Trial". The program aims to enhance delivery of HIV testing services (HTS) in emergency departments (EDs) in Kenya, targeting hard-to-reach populations like men, adolescents,...
- The University of Washington (UW) was awarded a $1,246,486 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) on May 13, 2025. The purpose of this grant is to establish the Research Alliance in Implementation Science to End HIV (RAISE) Regional Consultative Hub, which will support Ending the HIV Epidemic (EHE) implementation science efforts in priority jurisdictions. Through...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,972 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation for the State University of New York, doing business as Sponsored Projects Services, to study the role of the cellular protein EHD4 in restricting HIV-1 infection. The research aims to determine the mechanism by which EHD4 decreases the infectivity of HIV-1 particles by impacting the incorporation of...
- The University of California, San Diego (UCSD) received a $702,788 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), to establish the San Diego Implementation Science Hub (SD IS Hub). The SD IS Hub applies implementation science principles to support the objectives of the NIH Ending the HIV Epidemic (EHE) initiative by providing technical consultation and support to...
- This federal Project Grant award of $738,030 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the University of Alabama at Birmingham (UAB) in establishing the UAB Regional Consultation Hub for Precision HIV Implementation Science. The Hub serves as a resource for investigators and community partners in the U.S. Deep South region, which is heavily burdened by HIV. Over the 5-year award...